TR004

Developed for: Crohn disease
Investigated by: Guy's and St Thomas' NHS Foundation Trust · King's College London · Medical Research Council · Miltenyi biotech · St. George's Hospital, London

today NCT03185000 · Ph 1

2023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT03185000	Aug 2022 → Mar 2024	Crohn disease	King's College London	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	TR004	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03185000 ↗
Route	Intravenous	“Administered Intravenously (IV)” NCT03185000 ↗